Literature DB >> 22502799

Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice.

Bethany J Hsia1, Julie G Ledford, Erin N Potts-Kant, Vinayak S Nikam, Njira L Lugogo, W Michael Foster, Monica Kraft, Soman N Abraham, Jo Rae Wright.   

Abstract

BACKGROUND: Mycoplasma pneumoniae (Mp) frequently colonizes the airways of patients with chronic asthma and likely contributes to asthma exacerbations. We previously reported that mice lacking surfactant protein A (SP-A) have increased airway hyperresponsiveness (AHR) during M pneumoniae infection versus wild-type mice mediated by TNF-α. Mast cells (MCs) have been implicated in AHR in asthma models and produce and respond to TNF-α.
OBJECTIVE: Determine the contribution of MC/TNF interactions to AHR in airways lacking functional SP-A during Mp infection.
METHODS: Bronchoalveolar lavage fluid was collected from healthy and asthmatic subjects to examine TNF-α levels and M pneumoniae positivity. To determine how SP-A interactions with MCs regulate airway homeostasis, we generated mice lacking both SP-A and MCs (SP-A(-/-)Kit(W-sh/W-sh)) and infected them with M pneumoniae.
RESULTS: Our findings indicate that high TNF-α levels correlate with M pneumoniae positivity in human asthmatic patients and that human SP-A inhibits M pneumoniae-stimulated transcription and release of TNF-α by MCs, implicating a protective role for SP-A. MC numbers increase in M pneumoniae-infected lungs, and airway reactivity is dramatically attenuated when MCs are absent. Using SP-A(-/-)Kit(W-sh/W-sh) mice engrafted with TNF-α(-/-) or TNF receptor (TNF-R)(-/-) MCs, we found that TNF-α activation of MCs through the TNF-R, but not MC-derived TNF-α, leads to augmented AHR during M pneumoniae infection when SP-A is absent. Additionally, M pneumoniae-infected SP-A(-/-)Kit(W-sh/W-sh) mice engrafted with TNF-α(-/-) or TNF-R(-/-) MCs have decreased mucus production compared with that seen in mice engrafted with wild-type MCs, whereas burden was unaffected.
CONCLUSION: Our data highlight a previously unappreciated but vital role for MCs as secondary responders to TNF-α during the host response to pathogen infection.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502799      PMCID: PMC3578696          DOI: 10.1016/j.jaci.2012.03.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  39 in total

Review 1.  Cellular engineering in a minimal microbe: structure and assembly of the terminal organelle of Mycoplasma pneumoniae.

Authors:  Duncan C Krause; Mitchell F Balish
Journal:  Mol Microbiol       Date:  2004-02       Impact factor: 3.501

Review 2.  Mast-cell responses to pathogens.

Authors:  Jean S Marshall
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

3.  Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation.

Authors:  Cong Jin; Christopher P Shelburne; Guojie Li; Erin N Potts; Kristina J Riebe; Gregory D Sempowski; W Michael Foster; Soman N Abraham
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

4.  CCR1 expression and signal transduction by murine BMMC results in secretion of TNF-alpha, TGFbeta-1 and IL-6.

Authors:  Nimita H Fifadara; Cho Cho Aye; Sandeep K Raghuwanshi; Ricardo M Richardson; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-07-10       Impact factor: 4.823

5.  The mast cell in normal human bronchus and lung.

Authors:  G L Brinkman
Journal:  J Ultrastruct Res       Date:  1968-04

6.  Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells.

Authors:  Karen G Brinker; Hollie Garner; Jo Rae Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09-13       Impact factor: 5.464

7.  Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection.

Authors:  James B McLachlan; Justin P Hart; Salvatore V Pizzo; Christopher P Shelburne; Herman F Staats; Michael D Gunn; Soman N Abraham
Journal:  Nat Immunol       Date:  2003-11-02       Impact factor: 25.606

8.  Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway.

Authors:  John F Alcorn; Jo Rae Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-05       Impact factor: 5.464

9.  Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

Authors:  Monica Kraft; Gail H Cassell; Juno Pak; Richard J Martin
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

Review 10.  Mast cells in allergic asthma and beyond.

Authors:  Sebastian Reuter; Michael Stassen; Christian Taube
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

View more
  9 in total

1.  Correction notice for TNF-R on mast cells regulate airway responses to Mycoplasma pneumoniae.

Authors:  Bethany J Hsia; Julie G Ledford; Erin N Potts-Kant; Vinayak S Nikam; Njira L Lugogo; W Michael Foster; Monica Kraft; Soman N Abraham; Jo Rae Wright
Journal:  J Allergy Clin Immunol       Date:  2015-11-21       Impact factor: 10.793

2.  Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.

Authors:  Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

3.  CC16 Deficiency in the Context of Early-Life Mycoplasma pneumoniae Infection Results in Augmented Airway Responses in Adult Mice.

Authors:  Natalie Iannuzo; Michael Insel; Craig Marshall; William P Pederson; Kenneth J Addison; Francesca Polverino; Stefano Guerra; Julie G Ledford
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.609

Review 4.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

5.  A 20-Mer Peptide Derived from the Lectin Domain of SP-A2 Decreases Tumor Necrosis Factor Alpha Production during Mycoplasma pneumoniae Infection.

Authors:  Usir S Younis; Hong Wei Chu; Monica Kraft; Julie G Ledford
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

6.  TNF Production in Activated RBL-2H3 Cells Requires Munc13-4.

Authors:  Tolulope E Ayo; Pratikshya Adhikari; Shuzo Sugita; Hao Xu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

7.  High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.

Authors:  Ying Ding; Chu Chu; Yuqin Li; Gen Li; Xiaoli Lei; Weifang Zhou; Zhengrong Chen
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

8.  High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.

Authors:  Gang Li; Liping Fan; Yuqing Wang; Li Huang; Meijuan Wang; Canhong Zhu; Chuangli Hao; Wei Ji; Hansi Liang; Yongdong Yan; Zhengrong Chen
Journal:  Mol Med       Date:  2019-08-09       Impact factor: 6.354

Review 9.  Surfactant Protein-A Function: Knowledge Gained From SP-A Knockout Mice.

Authors:  Lynnlee Depicolzuane; David S Phelps; Joanna Floros
Journal:  Front Pediatr       Date:  2022-01-07       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.